Neuronetics Partners with Elite DNA for Mental Health Excellence
MALVERN, Pa. — Neuronetics, Inc. (NASDAQ: STIM), a pioneering leader in medical technology aimed at enhancing the quality of life for those grappling with neurohealth disorders, recently announced an exciting three-year exclusive partnership with Elite DNA Behavioral Health. This collaboration is designed to expand the reach of NeuroStar, allowing the effective transcranial magnetic stimulation (TMS) therapy to be available in over 30 locations of Elite DNA, which stands as one of Florida's largest mental health networks. Through this agreement, Neuronetics not only aims to provide its innovative TMS devices but also to furnish Elite DNA with operational support services via its Greenbrook platform.
Expanding Access to Life-Changing Therapy
Keith J. Sullivan, President and CEO of Neuronetics, expressed his enthusiasm for this collaboration, emphasizing the importance of partnership in increasing accessibility to proven mental health interventions. He stated, “Together, we’re expanding NeuroStar’s reach and helping even more patients access proven, life-changing TMS therapy through a scalable, systemized model of care.” This collaboration is a strategic move designed to operationalize the benefits identified during Neuronetics' recent acquisition of Greenbrook.
Enhancing Patient Support Services
Through this exclusive partnership, Neuronetics plans to establish a dedicated subsidiary aimed at improving patient support services offered by Elite DNA. These services will include patient health questionnaire processing, TMS consultations, and scheduling assistance. By leveraging the existing operational expertise of Greenbrook, the Elite DNA team can redirect their focus toward enriching the patient experience, ensuring that care components are seamless and efficient.
Commitment to Accessibility in Mental Health Care
Elizabeth Dosoretz, LCSW and Founder of Elite DNA, emphasized the shared commitment of both organizations to eliminate barriers in mental health treatment. “Working with Neuronetics allows us to continue advancing our mission to provide comprehensive, evidence-based care accessible to every community we serve,” she noted. This collaboration represents a significant step towards increasing access to advanced mental health treatments.
Seamless Integration of Care Models
Dr. Omar Rieche, Chief Medical Officer at Elite DNA, echoed the sentiment surrounding the partnership, stating, “Our teams are dedicated to ensuring that every patient receives timely, coordinated, and compassionate care.” This collaboration allows for a seamless integration of TMS therapy treatments into the care models already in place, paving the way for improved patient access to various advanced treatment options while maintaining high clinical standards across clinics.
Future Plans for Expansion
The initiation of this partnership began with a pilot launch expected in the latter portion of 2025, with planned expansion in the following year. This proactive approach not only seeks to enhance current operations but aims to create a replicable model that can be extended to other organizations striving for excellence in mental health services.
About Elite DNA Behavioral Health
Founded in 2013, Elite DNA Behavioral Health is committed to delivering accessible mental health care. Celebrating its 12th anniversary, it has grown to become one of Florida's foremost providers of both in-person and virtual behavioral health services, catering to children, adolescents, and adults. With more than 30 locations across Florida and Virginia, Elite DNA accepts a diverse range of insurance options and provides financial assistance to eligible patients, ensuring that care is attainable to all.
About Neuronetics
Neuronetics, Inc. holds the belief that mental health is as crucial as physical health. As a frontrunner in neuroscience, the company offers cutting-edge in-office treatment options to patients and healthcare providers. The NeuroStar Advanced Therapy serves as a non-invasive treatment approach that improves the lives of individuals suffering from neurohealth conditions, particularly when conventional medication has proven ineffective. With a reputation for excellence, Neuronetics operates numerous Greenbrook TMS centers across the United States, providing excellent mental health treatments.
Frequently Asked Questions
What is the significance of the partnership between Neuronetics and Elite DNA?
This partnership allows for expanded access to TMS therapy across Elite DNA's locations, enhancing mental health treatment availability.
What services will Neuronetics provide to Elite DNA?
Neuronetics will offer patient support services, including consultation and scheduling, to improve operational efficiency at Elite DNA.
When did the expanded partnership commence?
The partnership began with a pilot launch planned for late 2025, followed by an expansion in 2026.
How does Neuronetics contribute to mental health treatment?
Neuronetics provides innovative, non-invasive psychiatric therapies that address conditions where traditional medications may fall short.
What is NeuroStar Advanced Therapy?
NeuroStar Advanced Therapy is a leading TMS treatment for major depressive disorder (MDD), known for its effectiveness and safety profile in treating various mental health conditions.
